Ascentage Pharma Group International (HK:6855) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ascentage Pharma Group International has announced the members of its board of directors, highlighting a diverse team led by Executive Director Dr. YANG Dajun. The board comprises both non-executive and independent non-executive directors with significant expertise in the industry. This leadership structure is poised to guide the company in its strategic endeavors.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.